Source: BioPortfolio

Nanotherapeutics: Nanotherapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 10052017 Prices from USD $250

SummaryNanotherapeutics Inc Nanotherapeutics is a biopharmaceutical company that develops and manufactures biopharmaceutical products. The company's products include H5N1 Indonesia river vaccine H9N2 NTC0510 for acute pain NTI851 for clostridium difficil...

Read full article »
Nanotherapeutics's Competitors | Nanotherapeutics's News | Nanotherapeutics's Financials
Stay up-to-date with the latest news on Nanotherapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Peter H. Khoury's photo - President & CEO of Nanotherapeutics

President & CEO

Peter H. Khoury

CEO Approval Rating

71/100

Read more
Stay up-to-date with the latest news on Nanotherapeutics